Client News

Syntekabio Signs Memorandum of Understanding with bioSeedin/ACROBiosystems

Medigene AG Announces Lead Selection for MDG2021, Expanding TCR-T KRAS Library Targeting Solid Tumors

Affluent Medical Achieves the Clinical Objective of the Dry Pilot Study in the First Two Patients with the Artus Artificial Urinary Sphincter

Newron Pharmaceuticals 2024 Investor Day on June 25, 2024, in New York City

CARBIOS and TOMRA Textiles Join Forces to Scale Circularity of Polyester Textiles

Formycon Reports on the Results of the Annual General Meeting

Formycon Starts Clinical Development Program for FYB206, a Biosimilar Candidate for Immuno-Oncology Blockbuster Drug Keytruda

Tacalyx Extends Seed Round to over €14 M to Advance Development of its Cancer Therapeutics Targeting TACAs

Galimedix Therapeutics Establishes Scientific Advisory Board of Renowned Retina Experts as Company Prepares to Enter Phase 2 Clinical Study with GAL-101

Newron Pharmaceuticals will Host its 2024 Investor Day on June 25 in New York City